Preoperative Metabolic Syndrome Is Predictive of Significant Gastric Cancer Mortality after Gastrectomy: The Fujian Prospective Investigation of Cancer (FIESTA) Study
Open Access
- 1 February 2017
- journal article
- Published by Elsevier in EBioMedicine
- Vol. 15, 73-80
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Fujian Province (2015J01451, 2016J01508, 2016J01513)
- Training Project for Young and Middle-Aged Core Talents of Health System of Fujian Province (2015-ZQN-JC-7, 2015-ZQN-JC-22)
- Science and Technology Plan Projects of Fujian Province (2014Y0019)
- National Clinical Key Specialty Construction Program of China (2013-544)
This publication has 33 references indexed in Scilit:
- Insulin resistance and cancer: the role of insulin and IGFsEndocrine-Related Cancer, 2012
- Insulin resistance: A significant risk factor of endometrial cancerGynecologic Oncology, 2012
- Aberrant Gene Methylation Is a Biomarker for the Detection of Cancer Cells in Peritoneal Wash Samples from Advanced Gastric Cancer PatientsAnnals of Surgical Oncology, 2011
- Biomarkers of the Metabolic Syndrome and Breast Cancer PrognosisCancers, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Insulin resistance and hyperinsulinaemia in the development and progression of cancerClinical Science, 2009
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Metabolic syndrome as a prognostic factor for breast cancer recurrencesInternational Journal of Cancer, 2006
- Definition of Metabolic SyndromeCirculation, 2004
- Human blood pressure determination by sphygmomanometry.Circulation, 1993